Lv12
80 积分 2025-09-11 加入
The Nonclinical Safety Assessment of a Novel Anti-CEACAM5 Antibody Exatecan Conjugate Predicts a Low Risk for Interstitial Lung Disease (ILD) in Patients—The Putative Mechanism Behind ILD
21天前
已完结
Antibody–Exatecan Conjugates with a Novel Self-immolative Moiety Overcome Resistance in Colon and Lung Cancer
28天前
已完结
NK Cells Mediate T-cell Inflammation in the Tumor Microenvironment
29天前
已完结
Preclinical Development of MGC028, an ADAM9-Targeted, Glycan-Linked, Exatecan-Based Antibody–Drug Conjugate for the Treatment of Solid Cancers
1个月前
已完结
Safety, Efficacy and pharmacokinetics of T1h, a humanized anti-CD6 monoclonal antibody, in moderate to severe chronic plaque psoriasis - Results from a randomized phase II trial
1个月前
已关闭
Frontline: Optimal T cell activation requires the engagement of CD6 and CD166
1个月前
已完结
Human CD6 possesses a large, alternatively spliced cytoplasmic domain
1个月前
已完结
Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study
1个月前
已完结
Expression and Characterization of a Novel CD6 Ligand in Cells Derived from Joint and Epithelial Tissues1
2个月前
已完结
皖公网安备34019202002308
